All Type of News
KFDA approves new indication of Crestor, “therosclerosis”
AstraZeneca Korea says that the Korea Food and Drug Administration has approved Crestor (rosuvastatin calcium) as an adjunct to diet to slow the progression of atherosclerosis in patients with elevated cholesterol.
...
KFDA’s regional agencies to be disbanded
The six regional agencies of the Korea Food and Drug Administration will be disbanded, and government work related to the drug and medical device industries are likely to be integrated under the central KFDA.
The s...
Civic groups back government’s evaluation plan
Local five civic groups said that the government should push up with its plan to evaluate the economic effectiveness of conventional medicines between 2007 and 2011 and gradually readjust prices and exclude items that...
Price of Vixgrel, anti-clotting medicine, irks generic drug makers
Now all eyes are on the National Health Insurance Corporation’s decision on the price of Daewoong Pharm’s Vixgrel, a chemically modified medicine of Sanofi-Aventis’s Plavix.
The assessment is likely to be made avai...
Wholesaler showing skepticism over another price increase of Mentholatum lotion
The expected 10-percent price increase of Mentholatum lotion in July irritates drug wholesalers.
Many wholesalers said that if the price of Metholatum lotion rises from 2,900 won to 3,300 won, they will have to se...
94 pharmaceutical manufacturers uneasy about court ruling
The Seoul Administrative Court rejected an administrative suit against the Minister of Health, Welfare and Family Affairs, which was filed by 94 Korean pharmaceutical firms on June of last year, seeking a cancellation...
205 items to benefit from health insurance
The Ministry of Health, Welfare and Family Affairs has announced that 205 medicines will be eligible for health insurance from June 1.
Included in the 205 items are BMS Korea’s Sprycel and Chong Kun Dang’s Prigrel....
Soaring oil prices and weaker won to raise renowned OTC items from June
Influenced by rising international prices of crude oil and raw materials costs, the prices of such renowned OTC brand items as vitamin C preparations and hair dyes will rise 10-30 percent from next month.
Leading O...
Government’s new drug pricing policy to meet backlash
After the Health Insurance Review Agency unveiled its assessment results of lipid-lowering agents last week, the agency is likely to meet backlash from the domestic pharmaceutical industry.
The nation’s two busines...
Shares of Yuyu, Yungjin rallied
Shares of two pharmaceutical companies – Yuyu and Yungjin - reached a record high during trading on May 27, driven by bright prospects of new drug development and pharmaceutical bulk export.
Yuyu shares ended up 1...
